Stanford, UCSF To Open New FDA-Funded Center for Excellence To Improve Clinical Trails, Drug Development
On Monday, officials at Stanford University and UC-San Francisco announced the creation of the Center of Excellence in Regulatory Science and Innovation. The center, which is funded by an initial $3.3 million FDA grant, will focus on research to boost testing for preclinical safety and efficacy, improve clinical trials and their evaluation and accelerate and better focus new drug development by pulling together various data sets.
- "Stanford, UCSF Target Better Drug Development in New FDA Partnership" (Leuty, "BiotechSF," San Francisco Business Times, 5/5).